Literature DB >> 33922824

Current State of Analgesia and Sedation in the Pediatric Intensive Care Unit.

Chinyere Egbuta1, Keira P Mason1.   

Abstract

Critically ill pediatric patients often require complex medical procedures as well as invasive testing and monitoring which tend to be painful and anxiety-provoking, necessitating the provision of analgesia and sedation to reduce stress response. Achieving the optimal combination of adequate analgesia and appropriate sedation can be quite challenging in a patient population with a wide spectrum of ages, sizes, and developmental stages. The added complexities of critical illness in the pediatric population such as evolving pathophysiology, impaired organ function, as well as altered pharmacodynamics and pharmacokinetics must be considered. Undersedation leaves patients at risk of physical and psychological stress which may have significant long term consequences. Oversedation, on the other hand, leaves the patient at risk of needing prolonged respiratory, specifically mechanical ventilator, support, prolonged ICU stay and hospital admission, and higher risk of untoward effects of analgosedative agents. Both undersedation and oversedation put critically ill pediatric patients at high risk of developing PICU-acquired complications (PACs) like delirium, withdrawal syndrome, neuromuscular atrophy and weakness, post-traumatic stress disorder, and poor rehabilitation. Optimal analgesia and sedation is dependent on continuous patient assessment with appropriately validated tools that help guide the titration of analgosedative agents to effect. Bundled interventions that emphasize minimizing benzodiazepines, screening for delirium frequently, avoiding physical and chemical restraints thereby allowing for greater mobility, and promoting adequate and proper sleep will disrupt the PICU culture of immobility and reduce the incidence of PACs.

Entities:  

Keywords:  PICU; PICU-acquired complications; analgesia; critically ill pediatric patient; delirium; sedation; withdrawal

Year:  2021        PMID: 33922824     DOI: 10.3390/jcm10091847

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  215 in total

1.  Morphine-6-glucuronide, a potent mu agonist.

Authors:  G W Pasternak; R J Bodnar; J A Clark; C E Inturrisi
Journal:  Life Sci       Date:  1987-12-28       Impact factor: 5.037

Review 2.  Non-invasive patient-controlled analgesia in the management of acute postoperative pain in the hospital setting.

Authors:  Bart Morlion; Michael Schäfer; Neil Betteridge; Eija Kalso
Journal:  Curr Med Res Opin       Date:  2018-05-09       Impact factor: 2.580

Review 3.  Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children.

Authors:  Amanda C Capino; Jamie L Miller; Peter N Johnson
Journal:  Pharmacotherapy       Date:  2016-11-25       Impact factor: 4.705

4.  Consensus guidelines on sedation and analgesia in critically ill children.

Authors:  Stephen Playfor; Ian Jenkins; Carolyne Boyles; Imti Choonara; Gerald Davies; Tim Haywood; Gillian Hinson; Anton Mayer; Neil Morton; Tanya Ralph; Andrew Wolf
Journal:  Intensive Care Med       Date:  2006-05-13       Impact factor: 17.440

5.  Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial.

Authors:  Mary Ellen McCann; Jurgen C de Graaff; Liam Dorris; Nicola Disma; Davinia Withington; Graham Bell; Anneke Grobler; Robyn Stargatt; Rodney W Hunt; Suzette J Sheppard; Jacki Marmor; Gaia Giribaldi; David C Bellinger; Penelope L Hartmann; Pollyanna Hardy; Geoff Frawley; Francesca Izzo; Britta S von Ungern Sternberg; Anne Lynn; Niall Wilton; Martin Mueller; David M Polaner; Anthony R Absalom; Peter Szmuk; Neil Morton; Charles Berde; Sulpicio Soriano; Andrew J Davidson
Journal:  Lancet       Date:  2019-02-14       Impact factor: 79.321

Review 6.  Opioid tolerance and dependence in infants and children.

Authors:  K J Anand; J H Arnold
Journal:  Crit Care Med       Date:  1994-02       Impact factor: 7.598

7.  Optimizing Sedation Management to Promote Early Mobilization for Critically Ill Children.

Authors:  Mary Saliski; Sapna R Kudchadkar
Journal:  J Pediatr Intensive Care       Date:  2015-09-01

8.  Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

Authors:  Georges Mion; Thierry Villevieille
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

9.  Patient, Process, and System Predictors of Iatrogenic Withdrawal Syndrome in Critically Ill Children.

Authors:  Kaitlin M Best; David Wypij; Lisa A Asaro; Martha A Q Curley
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

10.  Prospectively assessed neurodevelopmental outcomes in studies of anaesthetic neurotoxicity in children: a systematic review and meta-analysis.

Authors:  Caleb Ing; William M Jackson; Michael J Zaccariello; Terry E Goldberg; Mary-Ellen McCann; Anneke Grobler; Andrew Davidson; Lena Sun; Guohua Li; David O Warner
Journal:  Br J Anaesth       Date:  2020-11-27       Impact factor: 9.166

View more
  3 in total

1.  Quality of clinical practice guidelines and recommendations for the management of pain, sedation, delirium and iatrogenic withdrawal in pediatric intensive care: a systematic review protocol.

Authors:  Ibo MacDonald; Marie-Hélène Perez; Vivianne Amiet; Alexia Trombert; Anne-Sylvie Ramelet
Journal:  BMJ Paediatr Open       Date:  2022-02-15

2.  Pain and sedation management and monitoring in pediatric intensive care units across Europe: an ESPNIC survey.

Authors:  Marco Daverio; Florian von Borell; Angela Amigoni; Erwin Ista; Anne-Sylvie Ramelet; Francesca Sperotto; Paula Pokorna; Sebastian Brenner; Maria Cristina Mondardini; Dick Tibboel
Journal:  Crit Care       Date:  2022-03-31       Impact factor: 9.097

Review 3.  Implementation Science in Pediatric Critical Care - Sedation and Analgesia Practices as a Case Study.

Authors:  Youyang Yang; Alon Geva; Kate Madden; Nilesh M Mehta
Journal:  Front Pediatr       Date:  2022-07-04       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.